Single-agent ibrutinib demonstrates efficacy and safety in patients with relapsed/refractory marginal zone lymphoma: A multicenter, open-label, phase 2 study Meeting Abstract
| Authors: | Noy, A.; de Vos, S.; Thieblemont, C.; Martin, P.; Flowers, C.; Morschhauser, F.; Collins, G. P.; Ma, S.; Coleman, M.; Peles, S.; Smith, S.; Smith, A.; Munneke, B.; Dimery, I.; Beaupre, D.; Chen, R. W. |
| Abstract Title: | Single-agent ibrutinib demonstrates efficacy and safety in patients with relapsed/refractory marginal zone lymphoma: A multicenter, open-label, phase 2 study |
| Meeting Title: | 58th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 128 |
| Issue: | 22 |
| Meeting Dates: | 2016 Dec 3-6 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2016-12-02 |
| Language: | English |
| ACCESSION: | WOS:000394446803124 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V128.22.1213.1213 |
| Notes: | Meeting Abstract: 1213 -- Source: Wos |
